Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/36138
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | VAN WIJMEERSCH, Bart | - |
dc.contributor.author | Comi, G. | - |
dc.contributor.author | Oreja-Guevara, C. | - |
dc.contributor.author | Wiendl, H. | - |
dc.contributor.author | Wuerfel, J. | - |
dc.contributor.author | Buffels, R. | - |
dc.contributor.author | Dirks, P. | - |
dc.contributor.author | Kuenzel, T. | - |
dc.contributor.author | Kadner, K. | - |
dc.contributor.author | Vermersch, P. | - |
dc.date.accessioned | 2021-12-11T19:57:22Z | - |
dc.date.available | 2021-12-11T19:57:22Z | - |
dc.date.issued | 2021 | - |
dc.date.submitted | 2021-12-08T09:43:48Z | - |
dc.identifier.citation | MULTIPLE SCLEROSIS JOURNAL, 27 (2_SUPPL) , p. 543 -544 | - |
dc.identifier.uri | http://hdl.handle.net/1942/36138 | - |
dc.language.iso | en | - |
dc.publisher | SAGE PUBLICATIONS LTD | - |
dc.title | Efficacy and safety of ocrelizumab in patients with RRMS with suboptimal response to prior disease-modifying therapies: 3-year data from CASTING and LIBERTO 1-year interim results | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 544 | - |
dc.identifier.issue | 2_SUPPL | - |
dc.identifier.spage | 543 | - |
dc.identifier.volume | 27 | - |
local.format.pages | 2 | - |
local.bibliographicCitation.jcat | M | - |
local.publisher.place | 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND | - |
local.type.refereed | Refereed | - |
local.type.specified | Meeting Abstract | - |
dc.identifier.isi | WOS:000706771302003 | - |
local.provider.type | wosris | - |
local.uhasselt.uhpub | yes | - |
local.description.affiliation | [Van Wijmeersch, B.] Hasselt Univ, Univ MS Ctr, Pelt, Hasselt, Belgium. | - |
local.description.affiliation | [Comi, G.] Univ Vita Salute San Raffaele, Milan, Italy. | - |
local.description.affiliation | [Oreja-Guevara, C.] Hosp Clin San Carlos, Madrid, Spain. | - |
local.description.affiliation | [Wiendl, H.] Univ Munster, Dept Neurol, Inst Translat Neurol, Munster, Germany. | - |
local.description.affiliation | [Wuerfel, J.] Univ Basel, Med Image Anal Ctr MIAC AG, Basel, Switzerland. | - |
local.description.affiliation | [Wuerfel, J.] Univ Basel, Dept Biomed Engn, Basel, Switzerland. | - |
local.description.affiliation | [Buffels, R.; Dirks, P.; Kuenzel, T.; Kadner, K.] F Hoffmann La Roche Ltd, Basel, Switzerland. | - |
local.description.affiliation | [Vermersch, P.] Univ Lille, Inserm U 1172 LilNCog, CHU Lille, FHU Precise, Lille, France. | - |
local.uhasselt.international | yes | - |
item.contributor | VAN WIJMEERSCH, Bart | - |
item.contributor | Comi, G. | - |
item.contributor | Oreja-Guevara, C. | - |
item.contributor | Wiendl, H. | - |
item.contributor | Wuerfel, J. | - |
item.contributor | Buffels, R. | - |
item.contributor | Dirks, P. | - |
item.contributor | Kuenzel, T. | - |
item.contributor | Kadner, K. | - |
item.contributor | Vermersch, P. | - |
item.fulltext | No Fulltext | - |
item.fullcitation | VAN WIJMEERSCH, Bart; Comi, G.; Oreja-Guevara, C.; Wiendl, H.; Wuerfel, J.; Buffels, R.; Dirks, P.; Kuenzel, T.; Kadner, K. & Vermersch, P. (2021) Efficacy and safety of ocrelizumab in patients with RRMS with suboptimal response to prior disease-modifying therapies: 3-year data from CASTING and LIBERTO 1-year interim results. In: MULTIPLE SCLEROSIS JOURNAL, 27 (2_SUPPL) , p. 543 -544. | - |
item.accessRights | Closed Access | - |
crisitem.journal.eissn | 2055-2173 | - |
Appears in Collections: | Research publications |
WEB OF SCIENCETM
Citations
1
checked on May 2, 2024
Page view(s)
50
checked on Aug 1, 2023
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.